Effects of a selective glucocorticoid receptor agonist on osteoblastic and osteoclastic cells

被引:0
|
作者
Rauner, M. [1 ]
Finger, S. [1 ]
Goettsch, C. [1 ]
Benad, R. [1 ]
Hofbauer, L. C. [1 ]
机构
[1] Tech Univ Dresden, Div Endocrinol Diabet & Bone Dis, Dept Med 3, Fac Med, Dresden, Germany
关键词
D O I
10.1016/j.bone.2009.03.582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S312 / S312
页数:1
相关论文
共 50 条
  • [1] Effects of a selective glucocorticoid receptor agonist on experimental keratoplasty
    Uwe Pleyer
    Jun Yang
    Sigrid Knapp
    Heike Schäcke
    Norbert Schmees
    Natasa Orlic
    Ljijana Otasevic
    Maurice De Ruijter
    Thomas Ritter
    Sigrid Keipert
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2005, 243 : 450 - 455
  • [2] Effects of a selective glucocorticoid receptor agonist on experimental keratoplasty
    Pleyer, U
    Yang, J
    Knapp, S
    Schäcke, H
    Schmees, N
    Orlic, N
    Otasevic, L
    De Ruijter, M
    Ritter, T
    Keipert, S
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (05) : 450 - 455
  • [3] Evaluation of the Selective Glucocorticoid Receptor Agonist Compound A for Ototoxic Effects
    Honeder, Clemens
    Engleder, Elisabeth
    Schoepper, Hanna
    Krause, Markus
    Landegger, Lukas David
    Plasenzotti, Roberto
    Gabor, Franz
    Gstoettner, Wolfgang
    Arnoldner, Christoph
    LARYNGOSCOPE, 2015, 125 (04): : E149 - E155
  • [4] Osteoblastic cells required for osteoclastic resorption but not for osteoclastic differentiation
    Owens, JM
    Gallagher, AC
    Chambers, TJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (11) : O6 - O6
  • [5] Beneficial Pharmacological Effects of Selective Glucocorticoid Receptor Agonist in External Eye Diseases
    Kato, Masatomo
    Hagiwara, Yumi
    Oda, Tomoko
    Imamura-Takai, Miwa
    Aono, Hiroyuki
    Nakamura, Masatsugu
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (04) : 353 - 360
  • [6] Osteoblastic cells required for osteoclastic resorption but not for osteoclastic differentiation.
    Owens, JM
    Gallagher, AC
    Chambers, TJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M406 - M406
  • [7] Dissociation of Osteogenic and Immunological Effects by the Selective Glucocorticoid Receptor Agonist, Compound A, in Human Bone Marrow Stromal Cells
    Rauner, Martina
    Goettsch, Claudia
    Stein, Nicola
    Thiele, Sylvia
    Bornhaeuser, Martin
    De Bosscher, Karolien
    Haegeman, Guy
    Tuckermann, Jan
    Hofbauer, Lorenz C.
    ENDOCRINOLOGY, 2011, 152 (01) : 103 - 112
  • [8] Discovery of a subnanomolar and selective spirocyclic agonist of the glucocorticoid receptor
    Badarau, Eduard
    Robert, Frederic
    Massip, Stephane
    Jakob, Florian
    Lucas, Simon
    Friebe, Daniela
    Hennen, Stephanie
    Frormann, Sven
    Ghosez, Leon
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 161 : 354 - 363
  • [9] Discovery of new selective glucocorticoid receptor agonist leads
    Berger, Markus
    Rehwinkel, Hartmut
    Schmees, Norbert
    Schaecke, Heike
    Edman, Karl
    Wissler, Lisa
    Reichel, Andreas
    Jaroch, Stefan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (03) : 437 - 442
  • [10] Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells
    Johnson, TE
    Vogel, R
    Rutledge, SJ
    Rodan, G
    Schmidt, A
    ENDOCRINOLOGY, 1999, 140 (07) : 3245 - 3254